Walgreens Boots Alliance
This coverage examines Walgreens Boots Alliance’s impact on UK retail, focusing on market entry, store formats, product assortments, supply chain practices, and pharmaceutical services. Reporting highlights strategic decisions, regulatory navigation, and operational developments—offering insights for pharmacy chain executives, healthcare retail managers, and professionals overseeing multichannel wellness and retail operations.
-
Mar- 2022 -21 MarchHigh Street
Boots bidders to begin discussions this week
Potential new owners of Boots are set to meet with the high street chemist chain’s management this week to discuss its £7bn upcoming sale, according to The Times. American private equity firms Apollo and Sycamore Partners are among the firms to have submitted non-binding bids for the Walgreens-owned group. They…
Read More » -
8 MarchPeople Moves
Ted Baker welcomes new CFO
Ted Baker has announced the appointment of Marc Dench as its new chief financial officer (CFO) with effect from today (8 March 2022). Dench will succeed David Wolffe in the role, who is leaving to pursue another opportunity and will resign as a director with immediate effect. Dench is described…
Read More » -
Feb- 2022 -24 FebruaryHealth & Beauty
CD&R rules out offer as Boots deadline hits
Walgreens Boots Alliance has reportedly set today (24 February) as the deadline to receive offers for the UK health and beauty chain Boots, according to Reuters. The outlet also revealed that private equity firm and new Morrisons owner CD&R has ruled itself out of the running amid the CMA’s ongoing…
Read More » -
14 FebruaryHigh Street
Boots bidders given end of month deadline
Prospective bidders for Boots reportedly have until the end of the month to submit their first-round bids in a £7bn auction of the business, The Times reported over the weekend. According to the paper, Boots UK CEO Sebastian James has been meeting with prospective bidders this week alongside advisers at…
Read More » -
3 FebruaryNews
Walgreens Boots Alliance adds to its board of directors
Walgreens Boots Alliance has announced the appointment of Steven Shulman to the company’s board of directors. He joins the board as a director, effective 27 January 2022, and becomes the board’s eleventh member. The firm said Shulman brings a “wealth” of healthcare management experience, as well as an “extensive” leadership…
Read More » -
Jan- 2022 -31 JanuaryHigh Street
Walgreens set to start £7bn Boots sale process
Walgreens Boots Alliance has reportedly started the sales process for its Boots international drugstore unit, according to Bloomberg. Walgreens is said to be “sending out preliminary information on the business to potential suitors ahead of first-round bids due in the coming weeks”. Boots, which has 2,200 stores in Britain and…
Read More » -
17 JanuaryHigh Street
Issa brothers eye Boots takeover
The Issa brothers are reportedly eyeing a takeover of high street giant Boots, which would see the Asda owners acquire more than 2,000 pharmacies and stores across the UK. According to the Mail on Sunday, the acquisition of the £10bn business is believed to have been discussed at a senior…
Read More » -
12 JanuaryHealth & Beauty
Bain Capital and CVC eye Boots takeover bid
Buyout firms Bain Capital and CVC Capital Partners have reportedly joined forces in an attempt to launch a takeover bid for high street chemist Boots. According to Sky News, Bain and CVC are assembling a joint bid and are said to have hired advisers from Lazard to help put a…
Read More » -
Dec- 2021 -6 DecemberHealth & Beauty
Boots owner mulls £10bn sale of chain
Walgreens Boots Alliance (WBA) is reportedly in talks with Goldman Sachs to discuss the potential disposal of the UK chemist chain in a deal valued at “well over” £5bn, according to Sky News. City sources told Sky that the chain’s value could be between £10bn and £12bn, adding that it…
Read More » -
Oct- 2021 -15 OctoberHigh Street
Boots owner sees Q4 sales surge 12% to $34bn
Walgreens Boots Alliance (WBA), the owner of Boots, has seen its sales for the Q4 period ending 31 August 2021 increase 12.8% to $34.3bn (£25bn). The UK high street brand itself saw comparable pharmacy sales increase 11.4% compared with the year-ago quarter, which it said reflected “stronger demand” for pharmacy…
Read More »
